DECISION TO STOP TYROSINE KINASE INHIBITORS (TKIS) WITH BONE MARROW LEUKEMIC STEM CELL LEVEL: DETECTION OF BCR-ABL IN PERIPHERAL BLOOD MAY NOT BE ENOUGH
25th European Hematology Congress Virtual, 11 - 21 Haziran 2020, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Lokman Hekim Üniversitesi Adresli: Evet